| Product NDC: | 49884-775 |
| Proprietary Name: | Clonidine |
| Non Proprietary Name: | Clonidine |
| Active Ingredient(s): | .2 mg/d & nbsp; Clonidine |
| Administration Route(s): | TRANSDERMAL |
| Dosage Form(s): | PATCH |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 49884-775 |
| Labeler Name: | Par Pharmaceutical, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076157 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090820 |
| Package NDC: | 49884-775-86 |
| Package Description: | 4 POUCH in 1 CARTON (49884-775-86) > 1 PATCH in 1 POUCH (49884-775-52) > 7 d in 1 PATCH |
| NDC Code | 49884-775-86 |
| Proprietary Name | Clonidine |
| Package Description | 4 POUCH in 1 CARTON (49884-775-86) > 1 PATCH in 1 POUCH (49884-775-52) > 7 d in 1 PATCH |
| Product NDC | 49884-775 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Clonidine |
| Dosage Form Name | PATCH |
| Route Name | TRANSDERMAL |
| Start Marketing Date | 20090820 |
| Marketing Category Name | ANDA |
| Labeler Name | Par Pharmaceutical, Inc. |
| Substance Name | CLONIDINE |
| Strength Number | .2 |
| Strength Unit | mg/d |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |